These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 7339730)

  • 1. [Hemodynamic effect of dobutamine in cardiogenic shock].
    Coma Canella I; López-Sendón J
    Rev Esp Cardiol; 1981; 34(6):483-9. PubMed ID: 7339730
    [No Abstract]   [Full Text] [Related]  

  • 2. [Catecholamines in internal medicine emergencies].
    Brandt D; Pristautz H; Klein W
    Wien Med Wochenschr; 1984 Jul; 134(13-14):324-7. PubMed ID: 6495745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of dobutamine in the treatment of post-infarction shock].
    Trojnar R; Kutarski A; Kedra WA; Rymar B; Markiewicz M
    Wiad Lek; 1983 Apr; 36(7):531-6. PubMed ID: 6349132
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hemodynamic study of shock in myocardial infarct].
    Foucault JP; Nicolas G; Bonhour JB; Potier JC; Guilleman D; Godin JF
    Arch Mal Coeur Vaiss; 1971 Jun; 64(6):887-98. PubMed ID: 4998996
    [No Abstract]   [Full Text] [Related]  

  • 5. Hemodynamic effects of levosimendan in acute myocardial infarction complicated by cardiogenic shock and high systemic vascular resistance.
    Tsagalou EP; Kanakakis J; Anastasiou-Nana MI; Drakos SG; Ntalianis AS; Malliaras K; Lazaris N; Katsaros F; Nanas JN
    Acute Card Care; 2009; 11(2):99-106. PubMed ID: 19353405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inotropic therapy for cardiac low output syndrome: comparison of hemodynamic effects of dopamine/dobutamine versus dopamine/dopexamine.
    El Mokhtari NE; Arlt A; Meissner A; Lins M
    Eur J Med Res; 2007 Nov; 12(11):563-7. PubMed ID: 18024265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiogenic shock in acute myocardial infarction].
    Martínez A; Corbalán R; González R; Asenjo R; Illanes G; Rodríguez JA
    Rev Med Chil; 1986 Oct; 114(10):947-53. PubMed ID: 2883711
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. A prospective, randomized pilot study.
    Levy B; Perez P; Perny J; Thivilier C; Gerard A
    Crit Care Med; 2011 Mar; 39(3):450-5. PubMed ID: 21037469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conventional hemodynamic resuscitation may fail to optimize tissue perfusion: an observational study on the effects of dobutamine, enoximone, and norepinephrine in patients with acute myocardial infarction complicated by cardiogenic shock.
    den Uil CA; Lagrand WK; van der Ent M; Nieman K; Struijs A; Jewbali LS; Constantinescu AA; Spronk PE; Simoons ML
    PLoS One; 2014; 9(8):e103978. PubMed ID: 25084171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical and hemodynamic study in patients with hypotension and shock complicating acute myocardial infarction].
    Xu YS; Gao RL; Yao KB
    Zhonghua Xin Xue Guan Bing Za Zhi; 1986 Apr; 14(2):88-90, 126. PubMed ID: 3743401
    [No Abstract]   [Full Text] [Related]  

  • 11. [Differential therapy of cardiogenic shock with dopamine/milrinone in comparison with dopamine/dobutamine].
    Meissner A; Schmelzle T; Simon R
    Z Kardiol; 1996 Nov; 85(11):839-46. PubMed ID: 9064946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of system and regional hemodynamic changes in experimental myocardial infarction, with reference to the effects of catecholamine.
    Mizutani T; Hazeki T
    Jpn Circ J; 1974 Jun; 38(6):479-83. PubMed ID: 4279995
    [No Abstract]   [Full Text] [Related]  

  • 13. Thrombolytic therapy in cardiogenic shock: effect of increased aortic pressure and rapid tPA administration.
    Garber PJ; Mathieson AL; Ducas J; Patton JN; Geddes JS; Prewitt RM
    Can J Cardiol; 1995 Jan; 11(1):30-6. PubMed ID: 7850662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hemodynamic effect of dobutamine in patients with cardiac insufficiency].
    Delius W; Wirtzfeld A; Sebening H
    Verh Dtsch Ges Kreislaufforsch; 1976; 42():197-200. PubMed ID: 1007566
    [No Abstract]   [Full Text] [Related]  

  • 15. [High-dose nitroglycerin in cardiogenic shock].
    Guglina ME
    Klin Med (Mosk); 1997; 75(6):27-30. PubMed ID: 9273395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiogenic shock caused by right ventricular infarction--new perspective for the use of hypertonic solutions].
    Serrano Júnior CV; Ramires JA
    Arq Bras Cardiol; 1991 Dec; 57(6):433-4. PubMed ID: 1824214
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of vasopressin on hemodynamics in patients with refractory cardiogenic shock complicating acute myocardial infarction.
    Jolly S; Newton G; Horlick E; Seidelin PH; Ross HJ; Husain M; Dzavik V
    Am J Cardiol; 2005 Dec; 96(12):1617-20. PubMed ID: 16360345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of levosimendan versus dobutamine on long-term survival of patients with cardiogenic shock after primary coronary angioplasty.
    Samimi-Fard S; García-González MJ; Domínguez-Rodríguez A; Abreu-González P
    Int J Cardiol; 2008 Jul; 127(2):284-7. PubMed ID: 17643519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon in the treatment of cardiogenic shock following acute myocardial infarction.
    O'Brien ET; Howarth E; Singh SP
    J Ir Med Assoc; 1973 Aug; 66(15):415-7. PubMed ID: 4727938
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cardiogenic shock].
    Kimata S; Takahashi S; Noda H; Shibata N; Miyazaki Y; Hirosawa K
    Nihon Rinsho; 1980; 38(4):1937-45. PubMed ID: 6997554
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.